Bela Kis M.D.

He is currently the lead investigator in a groundbreaking phase II transarterial chemoperfusion clinical trial for patients with unresectable pleural mesothelioma.

It involves identifying specific blood vessels that feed the tumors, then overloading those vessels with high doses of specific chemotherapy agents to stop the cancer growth without exposing the rest of the body.

He is heavily involved with image guided tumor therapy, image-guided biopsies and urinary and biliary interventions, arterial and venous stenting. He also does minimally invasive percutaneous tumor ablation.

Kis came to Moffitt after completing a radiology residency and interventional radiology fellowship at Brigham and Women’s Hospital, Harvard Medical School in Boston.

He holds a doctorate in cerebral microcirculation from University of Szeged in Hungary and did a post-doctoral fellowship and surgery internship at Wake Forest University Baptist Medical Center in Winston-Salem, North Carolina.